KDM1A and medulloblastoma: As expected, the use of LSD1 inhibitors, GSK-LSD1 and ORY-1001, attenuated the proliferation GIF1/GIF1B-driven medulloblastoma cells both in vitro and in mouse models with flank-implanted tumors, however, not those with intracranially implanted tumors (Figure 4).